During Pregnancy, Majority Of B.C. Women Take Prescription Drugs

Main Category: Pregnancy / Obstetrics

Also Included In: Pharmacy / Pharmacist;  Anxiety / Stress;  Sleep / Sleep Disorders / Insomnia

Article Date: 20 Dec 2011 – 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:



Patient / Public:not yet rated
Healthcare Prof:not yet rated



Almost two-thirds of women in British Columbia filled at least one prescription at some point in their pregnancy, including drugs with potential risks, according to a new study by University of British Columbia researchers.

The study, published online in the journal Clinical Therapeutics, is the first of its kind in Canada. Researchers analyzed population-based outpatient prescription claims data for patterns of prescription drug use during pregnancy in B.C. from 2001 to 2006.

The researchers found that 63.5 per cent of pregnant women in B.C. filled at least one prescription. One in thirteen – or 7.8 per cent – filled a prescription for a medicine known to be risky in pregnancy – most often for select medicines for anxiety, insomnia and depression. Drugs that are strictly contraindicated in pregnancy, however, were filled in less than 0.5% of pregnancies.

“Although much remains to be understood about the appropriateness of medicine use that actually occurs among pregnant women in B.C., one encouraging finding from our study is that existing use of medicines with known risks declines dramatically when women become pregnant,” says co-author Steve Morgan, an associate professor in the School of Population and Public Health (SPPH) and Associate Director of the Centre for Health Services and Policy Research (CHSPR).

On average, pregnant women filled 2.6 different types of drugs, while 15 per cent used five or more prescription medications during their pregnancy. Prescriptions most frequently filled during pregnancy were for antibiotics (30.5 per cent), respiratory drugs (25.7 per cent), dermatologics (13.4 per cent), and drugs that act on the nervous system (12.8 per cent).

Other study findings include:

  • The use of medicines in pregnancy slightly increased over time, going from 63 per cent of women in 2001 to 66 per cent in 2006.
  • Women aged 20 years or younger were most likely to take prescription drugs during pregnancy (69 per cent) while the lowest rate occurred among those aged 30 to 35 years (62 per cent).
  • Prescription medication use was also high in the first three months immediately following delivery, a period when women may be breastfeeding, with 61.3 per cent of women filling prescriptions.

“Since pregnant women are normally excluded from clinical trials of new drugs and post-market study is limited, there is little evidence on the risks and benefits of many of the most commonly used drugs in pregnancy,” says lead author Jamie Daw, a researcher at CHSPR, part of SPPH. “Given the prevalence of prescription drug use, more research is needed to help pregnant women and their physicians make informed decisions.”

  • Additional
  • References
  • Citations
Article adapted by Medical News Today from original press release. Click ‘references’ tab above for source.

Visit our pregnancy / obstetrics section for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA

University of British Columbia. “During Pregnancy, Majority Of B.C. Women Take Prescription Drugs.” Medical News Today. MediLexicon, Intl., 20 Dec. 2011. Web.
20 Dec. 2011. <http://www.medicalnewstoday.com/releases/239374.php>


APA
University of British Columbia. (2011, December 20). “During Pregnancy, Majority Of B.C. Women Take Prescription Drugs.” Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/239374.php.

Please note: If no author information is provided, the source is cited instead.


Rate this article:
(Hover over the stars then click to rate)
Patient / Public:
orHealth Professional:

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our
Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our

OTC Vitamin D (D3) More Effective Than Prescription Vitamin D (D2)

Editor’s Choice
Academic Journal

Main Category: Pharmacy / Pharmacist

Also Included In: Nutrition / Diet

Article Date: 18 Nov 2011 – 7:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:



Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:5 stars

5 (1 votes)



John J. Cannell, M.D writes that he receives numerous questions from individuals who ask, “My doctor prescribed Drisdol, is that OK?”

Drisdol is vitamin D2 in a form that doctors write prescriptions for. Sun exposure does not produce vitamin D2 in the body, the vitamin is produced by plant matter and irradiating fungus. When consumed, numerous metabolic forms of D2 can be traced in the body. According to some studies, vitamin D3, which is produced by the skin, is more powerful, hence more effective at raising blood levels compared with vitamin D2, however, some studies say they are equal. Few studies however have compared the efficiency of D2 versus D3, or, to put it simply, which form has better health outcomes and which better mortality rates?

Lead researcher, professor Dr. Goran Bjelakovic decided to investigate the question in a meta-analysis, which was followed by a recent review.

Bjelakovic evaluated 50 randomized controlled trials (RCTs) that included a total of 94,000 participants who took some form of vitamin D. Mortailty rates were reported as either primary of secondary outcomes. Whilst 74,000 participants in 32 trials used D3, the remaining 18,000 participants in the other 12 trials took D2. He discovered that the relative risk increased by 2% for participants in the vitamin D2-group, whilst those in the D3-group had a relative risk reduction of 6%.

Incredibly, the study was somehow overlooked and neither the press nor Cannell spotted it in July. Thanks to a recent review of the study by Professor Dr. Harvey Murff of Vanderbilt University in the Annals of Internal Medicine, the general public is now able to examine the study once again.

Cannell says:

“You would think a paper that took a look at tens of thousands of subjects and analyzed the efficacy of prescription vitamin D (D2) and over-the-counter vitamin D (D3) would warrant a news story or two. To my knowledge, these papers are the first to paint such a clear picture about the efficacy between D3 and D2. While there may be explanations for D3′s superiority other than improved efficacy, for the time being, these papers send doctors a message: use D3, not D2.”

Written by Grace Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

  • Additional
  • References
  • Citations
Visit our pharmacy / pharmacist section for the latest news on this subject.
Adapted from an article written by John J. Cannell, M.D.

”Vitamin D supplementation for prevention of mortality in adults”
Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C.
Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007470.

”Review: Cholecalciferol (vitamin D3) reduces mortality in adults; other forms of vitamin D do not”
Murff HJ.
Ann Intern Med. 2011; 155:JC5-04.

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Grace Rattue. “OTC Vitamin D (D3) More Effective Than Prescription Vitamin D (D2).” Medical News Today. MediLexicon, Intl., 18 Nov. 2011. Web.
18 Nov. 2011. <http://www.medicalnewstoday.com/articles/237943.php>


APA
Grace Rattue. (2011, November 18). “OTC Vitamin D (D3) More Effective Than Prescription Vitamin D (D2).” Medical News Today. Retrieved from
http://www.medicalnewstoday.com/articles/237943.php.

Please note: If no author information is provided, the source is cited instead.


Rate this article:
(Hover over the stars then click to rate)
Patient / Public:
orHealth Professional:

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our
Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our

Prescription Pain Medication Addiction Prevalent Among Chronic Pain Patients

Alcohol / Addiction / Illegal Drugs News

Main Category: Alcohol / Addiction / Illegal Drugs
Also Included In: Pain / Anesthetics;  Pharmacy / Pharmacist;  Psychology / Psychiatry
Article Date: 22 Jul 2011 – 1:00 PDT
email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated
Healthcare Prof:not yet rated

A new study by Geisinger Health System researchers finds a high prevalence of prescription pain medication addiction among chronic pain patients. In addition, researchers found that the American Psychiatric Association’s (APA) new definition of addiction, which was expected to reduce the number of people considered addicts who take these medicines, actually resulted in the same percentage of people meeting the criteria of addiction.

Published in the Journal of Addictive Diseases, the study found that 35 percent of patients undergoing long-term pain therapy with opioids like morphine, OxyContin, Percocet and Vicodin, meet the criteria for addiction.

“Most patients will not know if they carry the genetic risk factors for addiction,” said study lead Joseph Boscarino, senior investigator II, Geisinger Health System. “Improper or illegal use of prescription pain medication can become a lifelong problem with serious repercussions for users and their families.”

Boscarino added that “genetic predisposition to addiction further exacerbates the risks associated with misuse of prescription pain medication.”

Using electronic health records, a random sample of outpatients undergoing long-term opioid therapy for non-cancer pain was identified and 705 participants completed telephone interviews from August 2007 through November 2008.

When comparing the APA’s newly revised criteria for addiction with the old criteria, researchers were surprised to find the prevalence of and risk factors for addiction to be virtually the same. It was determined that different symptoms now qualify the same patients for inclusion who would have been excluded under the previous classification system.

The study states that pain medication addiction often happens in people under 65, with a history of opioid abuse, withdrawal symptoms and substance abuse treatment. Risk factors for severe pain medication addiction also include a history of anti-social personality disorder.

“Ultimately, we hope our research will aid the development of newer classes of medications that don’t negatively impact the brain and therefore avoid addiction entirely,” Boscarino said.

Researchers from New York University also contributed to the study.

Source: Geisinger Health System

View drug information on OxyContin.


Please rate this article:
(Hover over the stars
then click to rate)
Patient / Public:orHealth Professional:

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

twitter icon  Follow us on Twitter
news icon  Alcohol / Addiction / Illegal Drugs headlines
email icon  email to a friend
printer icon  printer friendly version
newsletter icon  weekly newsletter
star icon  personalize your news

back to top - icon  back to top


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to topBack to front pageList of All Medical Articles

MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions


MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.


ISMP Warns That Emphasizing Speed In Community Pharmacy Prescription Dispensing Can Lead To Errors

Pharmacy / Pharmacist News

Main Category: Pharmacy / Pharmacist
Article Date: 07 Jun 2011 – 1:00 PDT
email icon email to a friend   printer icon printer friendly   write icon opinions  

The Institute for Safe Medication Practices (ISMP) is sending a strong warning about a safety issue illustrated by a wave of recent national advertising-promoting and rewarding the speed at which community pharmacies dispense prescriptions. The Institute has written to the National Association of Boards of Pharmacy (NABP) to ask for its support in discouraging speed as a primary marketing tool for pharmacy services.

One of the largest pharmacy chains, Rite Aid Corporation, now advertises a “15-Minute Prescription Guarantee” where up to three new prescriptions will be dispensed within 15 minutes (average of about 5 minutes) or less. If a pharmacy fails to meet the mark, the customer receives a gift card. And other chains as well as independent pharmacies have initiated advertising campaigns that offer similar guarantees to motivate customers.

A 15-minute dispensing claim for up to three prescriptions can jeopardize public health by putting pressure on pharmacists to work as quickly as possible and discouraging them from checking the patient‟s history and drug profile; looking for possible drug interactions or duplications and other drug use evaluation concerns; calling physicians‟ offices for clarification; and educating patients about the proper use of prescriptions (as required by federal regulations).

ISMP has received reports from consumers about serious medication errors in community pharmacies where the pharmacist seemed so rushed that work could not be thoroughly checked. Examples of errors due to volume and workplace distractions have been published in the ISMP Medication Safety Alert! Community/Ambulatory Care Edition newsletter.

ISMP believes that prescription guarantees help promote the idea that the dispensing of medications is a „quick in and quick out process‟ concerned only with counting tablets. ISMP finds it unacceptable to hold pharmacists to an unrealistic timeframe that can lead to medication errors. Instead, pharmacies should promote the clinical activities they perform and the availability of patient education services.

ISMP applauds the decision by New York State to outlaw the use of “inducements” (e.g., gift cards, coupons) to garner business. We urge other states, through their boards of pharmacy, to follow New York‟s example.

In addition to writing to NABP, ISMP has featured this issue in the ISMP Medication Safety Alert! Acute Care and Ambulatory/Community Care editions as well as ISMP President Michael Cohen‟s health blog.

Source:
The Institute for Safe Medication Practices (ISMP)


Please rate this article:
(Hover over the stars
then click to rate)
Patient / Public:orHealth Professional:

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

twitter icon  Follow us on Twitter
news icon  Pharmacy / Pharmacist headlines
email icon  email to a friend
printer icon  printer friendly version
newsletter icon  weekly newsletter
star icon  personalize your news

back to top - icon  back to top


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to topBack to front pageList of All Medical Articles

MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions


MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.


People With MS Caught In Medicare “Donut Hole” Finding Critical Relief Under Affordable Care Act In Their Costs For Prescription Medications

Main Category: Multiple Sclerosis
Also Included In: Pharmacy / Pharmacist
Article Date: 31 May 2011 – 1:00 PDT
email icon email to a friend   printer icon printer friendly   write icon opinions  

As the average cost of MS in the United States is nearly $ 70,000 a year, with the overall annual economic cost of MS being an estimated $ 28 billion, people living with MS face high out-of-pocket costs even when covered by health insurance. The high out-of-pocket costs for medical care and treatment create not only a financial burden but also discourage people from starting and staying on therapy, which right now is the best approach available for preventing disease activity in people with relapsing MS, the most common form of the disease.

As part of the millions of Americans receiving their medical coverage through Medicare, people with MS have already begun to benefit from improvements to the Medicare prescription drug program included in the Affordable Care Act and are now receiving a 50% discount on covered brand name medications bought when they are in the “donut hole.” This is particularly important for people with MS as there are no generic equivalents at present for any of the FDA approved disease modifying therapies used by the MS population. For those on symptom management therapies where generic drugs are an option, a 7% discount is now being realized.

“To receive the discount for their prescribed medications, no special action is required, as the discount is automatically applied,” advises David Chatel, Executive Vice President, Advocacy at the National MS Society. “It is important, however, that our MS constituency on Medicare know of these new cost savings so that they continue with their needed medications.”

Approximately 25% of all people in the U.S. living with multiple sclerosis are Medicare beneficiaries, and most of them rely on Medicare prescription drug plans(Part D) for access to their medicines. But because their drug costs can be exceptionally high, many Part D members with MS hit the ‘coverage gap’ each year. The coverage gap, or so-called “donut hole,” is the period when Part D enrollees must pay 100% of their medication costs. In calendar year 2011 that coverage cap occurs when $ 2,840 has been spent on needed medications. Prescription drug coverage does not resume until the enrollee has incurred $ 4,550 in out of pocket medication costs bringing them to the Medicare catastrophic coverage level.

This increased financial relief for those stuck in the coverage donut hole builds on the 2010 one-time rebate of $ 250 given to Medicare Part D enrollees that hit the donut hole. These initial steps are part of the plan to eliminate the donut hole coverage gap by the end of the decade. These important benefits will improve the quality of life and financial stability of families affected by MS.

About Multiple Sclerosis

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain and between the brain and the body. Every hour in the United States, someone is newly diagnosed with the disease. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with more than twice as many women as men being diagnosed with the disease. MS affects more than 400,000 people in the U.S. and 2.1 million worldwide.

Source: National Multiple Sclerosis Society

Please rate this article:
(Hover over the stars
then click to rate)
Patient / Public:orHealth Professional:

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

twitter icon  Follow us on Twitter
news icon  Multiple Sclerosis headlines
email icon  email to a friend
printer icon  printer friendly version
newsletter icon  weekly newsletter
star icon  personalize your news

back to top - icon  back to top


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to topBack to front pageList of All Medical Articles

MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions


MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.


Survey: Most Aussies Buy Prescription Medication More Than 12 Times A Year, Australia

Pharma Industry / Biotech Industry News

Main Category: Pharma Industry / Biotech Industry
Article Date: 30 May 2011 – 1:00 PDT
email icon email to a friend   printer icon printer friendly   write icon opinions  

An independent consumer survey today revealed the length to which Australians rely on prescription medication, with 52% of respondents buying or refilling the products more than 12 times a year.

“We were surprised by the high level of prescription medication use shown by the survey. Interestingly, we saw males were more likely (52%) to buy or refill their prescriptions more than 12 times a year than females (48%),” said CANSTAR CANNEX’s Head of Research Steve Mickenbecker.

“Not surprisingly, baby boomer respondents were the generation most likely to use prescription medication at this level (64%). However, a significant percentage of the younger generations were also frequent users of prescription medication, with 35% of Generation Y respondents and 39% of Generation X respondents buying or refilling prescription medication more than 12 times a year.”

This follows a study released recently by Pfizer which showed less than a third of people adopt other healthy habits when taking prescription medication to manage their health condition.

Endeavour College of Health Director of Education Nick Vardaxis said too many Australians depend soley on medication to solve their health issues.

“Prescription medication has a strong place in the health equation, but Australians should also consider how much diet and exercise can help alleviate, and sometimes cure, their symptoms,” said Dr Vardaxis.

The Canstar Blue survey showed 1 in 10 Australians surveyed have experienced an adverse reaction to prescription medication in the past 12 months.

“This is a significant health issue, with an estimated 200,000 hospital admissions in Australia each year attributed to prescription medication,” said Mr Mickenbecker.

The results showed 13% of Australians surveyed buy a portion of their pharmacy products online. Generation Y respondents were significantly more likely (19%) to buy online than those from any other generation.

A tiny 3% of respondents buy all their pharmacy products online.

The independent Canstar Blue consumer satisfaction survey also revealed pharmacy brand Chemmart beat its competitors by coming out on top with most satisfied customers.

Customers scored Chemmart top marks for the categories of overall satisfaction, service, range, availability of pharmacists and advice provided. Chemist Warehouse was voted top by its customers for price.

Most Common Pharmacy Gripes

- Pharmacy cluttered inside with excessive shelving and product ranges.
- Impersonal service and uninformed staff.
- Lack of privacy to discuss medical conditions and ailments.
- Long waiting times to speak with the pharmacist and for prescriptions to be prepared.

Canstar Blue, a new initiative of CANSTAR CANNEX, commissions Colmar Brunton to survey 2,500 Australian consumers across a range of categories every few months to measure and track customer satisfaction. Chemmart today received the Most Satisfied Customers Award for Pharmacies.

The outcomes reported are the results from pharmacy customers within the survey group. To qualify, the customer has to have purchased from the pharmacy within the last 12 months.

“We launched Canstar Blue to give Australians a free online resource to help them with their key purchasing decisions by making it simple for them to learn from the experiences of other consumers. It is essentially a guide to product excellence as voted by customers,” Mr Mickenbecker said.

The independent survey was undertaken in conjunction with professional market researchers, Colmar Brunton.

What are the Canstar Blue ratings?

Canstar Blue researches, compares and rates the suite of products according to customer satisfaction across categories including banking, domestic airlines, telecommunications, cars, electronic retailers and plasma and LCD TVs. Results are freely available to consumers who are encouraged to use the ratings as a guide to product excellence. The use of similar ratings logos also builds consumer recognition of quality products across all categories.

Source:
Canstar Blue

Please rate this article:
(Hover over the stars
then click to rate)
Patient / Public:orHealth Professional:

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

twitter icon  Follow us on Twitter
news icon  Pharma Industry / Biotech Industry headlines
email icon  email to a friend
printer icon  printer friendly version
newsletter icon  weekly newsletter
star icon  personalize your news

back to top - icon  back to top


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to topBack to front pageList of All Medical Articles

MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions


MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.


DEA, Blue Cross And Shield Take Back Prescription Drugs In Initiative

Editor’s Choice
Main Category: Public Health
Also Included In: Pharmacy / Pharmacist
Article Date: 29 Apr 2011 – 11:00 PDT
email icon email to a friend   printer icon printer friendly   write icon opinions  

Well, the DEA is certainly not messing around in efforts to clear homes of potentially dangerous, expired, unused, and unwanted prescription drugs in the United States. This year on April 30 from 10 a.m. to 2 p.m., the DEA will have more than 5,100 locations across the U.S. available for the public to dispose unwanted prescription drugs. The service is free and anonymous, no questions asked.

In last year’s initiative, Americans turned in over 242,000 pounds, or 121 tons of prescription drugs at nearly 4,100 sites operated by more than 3,000 of the DEA’s state and local law enforcement partners.

In addition, Congress passed the Safe and Secure Drug Disposal Act of 2010, which amends the Controlled Substances Act to allow users of controlled substance medications to dispose of them by delivering them to entities authorized by the Attorney General to accept them.

Korn, M.D., senior vice president and chief medical officer of the Blue Cross and Blue Shield (BCBSA) said:

“Many do not know that prescription drug abuse is an epidemic. Unused prescription medicines that remain in homes can be misused or abused if they end up in the wrong hands of children, family or friends. BCBSA and Blue Cross and Blue Shield companies nationwide are leading efforts to increase patient safety and make it a healthcare priority and we commend the DEA’s efforts of providing a safe and easy way for Americans to drop off their unnecessary prescription drugs.”

Americans currently abuse prescription drugs more than the number of those using cocaine, hallucinogens, and heroin combined. The Partnership for a Drug Free America reports that each day, approximately, 2,500 teens use prescription drugs to get high for the first time. Studies show that a majority of abused prescription drugs are obtained from family and friends, including the home medicine cabinet.

DEA Administrator Michele Leonhart adds:

“The overwhelming public response to DEA’s first nationwide Take-Back event last fall not only rid homes of potentially harmful prescription drugs, but was an unprecedented opportunity to educate everyone about the growing prescription drug abuse problem. Studies have shown that, for many, prescription drugs are the very first drugs they abuse, and all too often they aren’t the last. That is why we are committed to helping Americans keep their homes safe by ridding their medicine cabinets of expired, unused, and unwanted drugs.”

Gil Kerlikowkse, Director of National Drug Control Policy had this to say to the nation:

“I encourage every American to take advantage of this valuable opportunity to safely dispose of unused, un-needed, or expired prescription drugs. Preventing these readily available and potentially deadly drugs from being diverted and misused is something each and every one of us can do to help reduce the epidemic of prescription drug abuse that is harming so many Americans. Prescription drug abuse is America’s fastest-growing drug problem, and one largely fed by an unlikely source, Americans’ medicine cabinets. The passage of the Secure and Responsible Drug Disposal Act of 2010 will save lives by providing patients with safe, environmentally sound ways to dispose of unused or expired prescription drugs.”

Sources: The DEA, Blue Cross and Blue Shield and click HERE for a copy of the actual Secure and Responsible Drug Disposal Act.

Written by Sy Kraft
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Please rate this article:
(Hover over the stars
then click to rate)
Patient / Public:orHealth Professional:

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

twitter icon  Follow us on Twitter
news icon  Public Health headlines
email icon  email to a friend
printer icon  printer friendly version
newsletter icon  weekly newsletter
star icon  personalize your news

back to top - icon  back to top


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to topBack to front pageList of All Medical Articles

MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions


MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.


ftrf - full text rss

Statement: APhA Supports ONDCP And FDA’s Plan To Address America’s Prescription Drug Abuse Problem

Alcohol / Addiction / Illegal Drugs News

Main Category: Alcohol / Addiction / Illegal Drugs
Also Included In: Pharmacy / Pharmacist;  Compliance
Article Date: 26 Apr 2011 – 1:00 PDT
email icon email to a friend   printer icon printer friendly   write icon opinions  

The American Pharmacists Association (APhA) announced its support of efforts by the White House to respond to America’s growing prescription drug abuse crisis. America’s pharmacists play a key role in the prevention of prescription drug abuse, through regular patient interaction, education and by providing clear information on how to take a medication correctly and appropriately, how and why to dispose of them properly and describing possible side effects or drug interactions.

Yesterday, White House officials from the Office of National Drug Control Policy (ONDCP), along with the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) released the Obama administration’s plan “Epidemic: Responding to America’s Prescription Drug Abuse Crisis.” The plan provides a national framework for reducing prescription drug diversion and abuse by supporting the expansion of state-based prescription drug monitoring programs, recommending more convenient and environmentally responsible disposal methods to remove unused medications from the home, supporting education for patients and health care providers, and reducing the prevalence of pill mills and doctor shopping through enforcement efforts.

The FDA also announced the final Risk Evaluation and Mitigation Strategy (REMS) programregarding all extended-release and long-acting opioid medications. APhA appreciates that the final opiod REMS program is one step in the Administration’s coordinated intergovernmental effort to address prescription drug abuse, proper pain management, education, storage and disposal.

APhA is actively advocating for strategies to improve REMS programs and systems, recently hosting a stakeholder meeting that included representative experts from various pharmacy, medicine, nursing, physician assistant, drug wholesaler, technology and safety organizations. The meeting was also observed by FDA representatives. APhA plans to publish the proceedings from the meeting as a white paper to serve as additional guidance to the FDA, manufacturers and other interested stakeholders.

Source:
American Pharmacists Association

Please rate this article:
(Hover over the stars
then click to rate)
Patient / Public:orHealth Professional:

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to topBack to front pageList of All Medical Articles

Privacy Policy | Terms and Conditions


MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.


ftrf - full text rss

Obama Plan Begins War On Illegal Prescription Use; OxyContin Focus

Pharma Industry / Biotech Industry News

Editor’s Choice
Main Category: Pharma Industry / Biotech Industry
Also Included In: Alcohol / Addiction / Illegal Drugs;  Pharmacy / Pharmacist
Article Date: 20 Apr 2011 – 9:00 PDT
email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated
Healthcare Prof:not yet rated

The United States has a problem, a big problem. Prescription drug abuse is taking over. For example, only 7% of OxyContin users got the drug from a doctor and 13% bought it from a drug dealer or other stranger. Nearly two-thirds got the drug from a friend or relative.

The new Obama Prescription Drug Abuse Prevention Plan calls on Congress to amend the Controlled Substances Act with a new requirement: that health care practitioners learn appropriate uses for opioid medicines and how to screen patients for drug abuse before they can get a Drug Enforcement Administration license to prescribe controlled substances.

The official plan can be found in a link at the bottom of this article, but some of the major initiatives include education, monitoring, proper medication disposal and enforcement.

Education, a crucial first step in tackling the problem of prescription drug abuse is intended to educate parents, youth, and patients about the dangers of abusing prescription drugs while requiring prescribers to receive education on the appropriate and safe use, and proper storage and disposal of prescription drug.

Another major goal is to begin prescription drug monitoring programs (PDMPs) in every state, and enhance PDMPs to make sure they can share data across states and are used by healthcare providers.

It is also very important that excess drugs are thrown away properly and safely. The government will attempt to install convenient and environmentally responsible prescription drug disposal programs to help decrease the supply of unused prescription drugs in the home.

Law enforcement will also get additional support with the tools necessary to eliminate improper prescribing practices and stop “doctor shoppers” or drug-seeking behavior.

Congress must require special training for doctors and other health care workers before they are allowed to prescribe powerful drugs such as OxyContin, White House drug czar Gil Kerlikowske said Tuesday.

Instances of recreational use and diversion of OxyContin have increased in the U.S. beginning in the late 1990s. A 2003 study by the Government Accountability Office found three factors that may have contributed to the illicit use and distribution of OxyContin in the U.S.

  1. OxyContin contains a large amount of oxycodone compared with other types of oxycodone containing pills.
  2. OxyContin’s warning label said to not crush the controlled-release tablets because of the potential for rapid release of oxycodone, which led to many people crushing the tablets and injecting or snorting the drug.
  3. By 2001, sales of OxyContin in the U.S. exceeded $ 1 billion per year.

Purdue Pharma, that manufactures the drug, has attempted to reformulate the 10 to 40 mg strengths of OxyContin to prevent the release of a high percentage of the oxycodone by crushing; however, in 2008 a joint panel convened by the U.S. Food and Drug Administration was “concerned that abusers could find a way to manipulate the new formulation.”
In 2010, Purdue Pharma introduced ‘Oxycontin OP’, Purdue Pharma predicts that abuse of higher dose formulations such as ‘OxyContin’ will go down, but this change may cause heavy recreational users to resort to other drugs such as heroin or may increase the number of deaths caused by acetaminophen poisoning from users attempting to take similar doses of drugs like ‘Percocet’ or ‘Vicodin’ to get similar effects.

American Medical Association President Cecil Wilson said his organization supports the intent of the drug abuse prevention plan but is concerned “that a key element of this strategy that relies on industry to develop educational materials and initiatives to train prescribers could in the future become a mandatory part of the DEA registration process for prescribing controlled substances.”

For the full plan titled Epidemic: Responding to America’s Prescription Drug Abuse Crisis, click HERE.

Additional Source: United States General Accounting Office

Written by Sy Kraft

View drug information on Oxycodone and Aspirin; OxyContin.

Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Please rate this article:
(Hover over the stars
then click to rate)
Patient / Public:orHealth Professional:

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to topBack to front pageList of All Medical Articles

Privacy Policy | Terms and Conditions


MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.